MGAM2 and Alzheimer disease: The observed elevation of glucan 1,4-alpha-glucosidase, an enzyme responsible for glycogen hydrolysis and glucose release, may represent a compensatory response to glucose deficiency, a hallmark of AD and potentially a feature of MCI converters.